prof. Filip Van den Bosch

Koen Venken (UGent) , Matthias Jarlborg (UGent) , Frederik Stevenaert, Thomas Malfait (UGent) , Carolien Vlieghe (UGent) , Yann Abraham, Teddy Manuello (UGent) , Tine Decruy (UGent) , Stijn Vanhee (UGent) , Hans Wils, et al.

(2024) ANNALS OF THE RHEUMATIC DISEASES. 84(3). p.409-420

Add to list

Journal Article
A1
open access

Upadacitinib in rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs : efficacy and safety through 5 years (SELECT-NEXT)

Gerd R. Burmester, Filip Van den Bosch (UGent) , John Tesser, Anna Shmagel, Yanxi Liu, Nasser Khan, Heidi S. Camp and Alan Kivitz

(2024) JOURNAL OF RHEUMATOLOGY. 51(7). p.663-672

Add to list

Journal Article
A1
open access

Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis

Martin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compan, Rachel Tham, Thomas Kumke, Lars Bauer, Natasha de Peyrecave, Mindy Kim and Filip Van den Bosch (UGent)

(2024) RMD OPEN. 10(3). p.1-10

Add to list

Journal Article
A1
open access

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial

U Kiltz, A Molto, C Lopez-Medina, M Dougados, D van der Heijde, A Boonen, Filip Van den Bosch (UGent) and J Braun

(2024) SEMINARS IN ARTHRITIS AND RHEUMATISM. 69.

Add to list

Journal Article
A1
open access

When usual care is not so usual : protocol violations and generalizability in a treat-to-target strategy trial in patients with axial spondyloarthritis

Clementina Lopez-Medina, Filip Van den Bosch (UGent) , Desiree van Der Heijde, Maxime Dougados and Anna Molto

(2024) ARTHRITIS CARE & RESEARCH. 76(11). p.1540-1548

Add to list

Journal Article
A1
open access

Classification criteria for axial disease in youth with juvenile spondyloarthritis

Pamela F. Weiss, Timothy G. Brandon, Amita Aggarwal, Ruben Burgos‐Vargas, Robert A. Colbert, Gerd Horneff, Ronald M. Laxer, Kirsten Minden, Angelo Ravelli, Nicolino Ruperto, et al.

(2024) ARTHRITIS & RHEUMATOLOGY. p.1797-1808

Academic Bibliography

prof. Filip Van den Bosch

Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA study

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study

Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis

Prevalence and incidence of uveitis in patients with spondyloarthritis : the impact of the biologics era : data from the international ASAS-COMOSPA study

Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking

Upadacitinib in rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs : efficacy and safety through 5 years (SELECT-NEXT)

Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial

When usual care is not so usual : protocol violations and generalizability in a treat-to-target strategy trial in patients with axial spondyloarthritis

Classification criteria for axial disease in youth with juvenile spondyloarthritis

Contents

Support

Contact